Healthcare Services

Nodular Prurigo Market Industry Outlook 2026–2030 Highlighting Growth Momentum And Market Trends

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Nodular Prurigo Market By 2030?

The nodular prurigo market size has demonstrated significant growth in recent years. It is anticipated to expand from $1.25 billion in 2025 to $1.33 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.6%. The expansion observed historically stems from several contributors, including the rising incidence of chronic dermatological conditions, the restricted efficacy of conventional topical treatments, increasing public understanding of pruritic skin ailments, the expansion of specialized dermatology clinics, and better diagnostic identification of nodular prurigo.

The nodular prurigo market size is anticipated to experience substantial expansion in the coming years, projected to reach $1.7 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period is driven by factors such as the increasing development of novel biologics and monoclonal antibodies, a growing emphasis on personalized dermatology treatments, rising investments in inflammatory skin disease research, the broadening of advanced immunotherapy pipelines, and an increasing demand for long-term itch control solutions. Key trends influencing this period include a greater adoption of targeted immunomodulatory therapies, an increased application of biologic treatments for chronic pruritus, a heightened focus on neuropathic itch management, the expansion of long-term disease management protocols, and an enhanced commitment to patient-centric dermatology care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24624&type=smp

Which Growth Factors Are Strengthening The Nodular Prurigo Market Landscape?

The increasing demand for targeted therapies is projected to fuel the growth of the nodular prurigo market in the future. Targeted therapies are medical treatments designed to specifically target and disrupt molecular pathways implicated in the growth and spread of diseases. The rising demand for these therapies can be attributed to their ability to provide more precise treatments with fewer side effects, leading to improved patient outcomes and offering alternatives to traditional, less specific treatments. Nodular prurigo itself helps stimulate the development of targeted therapies by presenting a distinct unmet medical need involving specific immune pathways like IL-4, IL-13, and IL-31. This allows for the use of biologics that precisely block these inflammatory signals for more effective treatment. For instance, according to the American Society of Gene & Cell Therapy, a US-based organization, in January 2024, the number of gene therapies in Phase III increased by 10% in Q4 2023 from the previous quarter, representing the first rise since Q3 2022. Therefore, this growing demand for targeted therapies is driving expansion in the nodular prurigo market.

What Segment Categories Are Evaluated In The Nodular Prurigo Market Study?

The nodular prurigo market covered in this report is segmented –

1) By Type: Chronic Nodular Prurigo, Acute Nodular Prurigo, Subacute Nodular Prurigo

2) By Treatment Type: Topical Treatments, Systemic Treatments, Phototherapy, Immunosuppressants

3) By Patient Demographics: Adults, Children, Elderly

4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Chronic Nodular Prurigo: Idiopathic Chronic Nodular Prurigo, Secondary To Dermatologic Conditions, Neuropathic Causes, Systemic Disease-Associated, Psychogenic Prurigo

2) By Acute Nodular Prurigo: Insect Bite-Induced, Allergic Reactions, Drug-Induced Prurigo, Infectious Triggers

3) By Subacute Nodular Prurigo: Healing Phase Of Chronic Prurigo, Post-Inflammatory Prurigo, Transient Dermatoses, Reaction To Environmental Irritants

Which Trends Are Expected To Shape The Nodular Prurigo Market?

Major companies operating in the nocturnal leg cramps treatment market are concentrating on securing regulatory approvals for new drugs to broaden their market reach and improve patient outcomes. Regulatory approvals denote the formal authorization granted by governmental or regulatory bodies, allowing a drug, medical device, or treatment to be marketed and used by the public. For example, in April 2023, Noctrix Health, a US-based medical equipment company, received FDA De Novo approval for its NTX100 Tonic Motor Activation (TOMAC) System. This system is intended to treat symptoms of moderate to severe restless legs syndrome (RLS) and enhance sleep quality for patients who are refractory to medications. The system comprises two therapy units worn on the lower legs, which deliver low-level electrical stimulation to the peroneal nerves, thereby inducing tonic muscle activation to suppress RLS symptoms. Clinical trials, including the RESTFUL study, demonstrated notable improvements in RLS symptoms and sleep quality, with no severe adverse events reported.

Who Are The Businesses Driving Activity In The Nodular Prurigo Market?

Major companies operating in the nodular prurigo market are Merck and Co Inc, Sanofi SA, GlaxoSmithKline plc, Amgen Inc, Regeneron Pharmaceuticals Inc, Astellas Pharma Inc, Sun Pharmaceutical Industries Limited, Galderma SA, Incyte Corporation, Kyowa Kirin Co Ltd, LEO Pharma AS, Maruho Co Ltd, Kiniksa Pharmaceuticals Ltd, Keymed Biosciences Co Ltd, Trevi Therapeutics Inc, Menlo Therapeutics Inc, VYNE Therapeutics Inc, Celldex Therapeutics Inc, AbbVie Inc, Pfizer Inc, Novartis AG, Eli Lilly and Company

Access The Complete Nodular Prurigo Market Report:

https://www.thebusinessresearchcompany.com/report/nodular-prurigo-global-market-report

Which Region Leads The Nodular Prurigo Market By Size?

North America was the largest region in the nodular prurigo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nodular prurigo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Nodular Prurigo Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24624&type=smp

Browse Through More Reports Similar to the Global Nodular Prurigo Market 2026, By The Business Research Company

Neuralgia Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Dental Sleep Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-sleep-medicine-global-market-report

Urea Cycle Disorders Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/urea-cycle-disorders-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795